# G+Flas Life Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/g-flas-life-sciences

- Industry: Biotechnology
- Headquarters: Cheongju, South Korea
- Website: www.gflas.com
- Total disclosed funding: $26M
- Latest round: Series C (Aug 22, 2019)
- Investors on record: 10

## About

Based in Seoul, South Korea, and founded in 2014, G+Flas Life Sciences, Inc develops new protein drugs for rare genetic diseases using gene scissors technology. In 2014, the company started joint research with Seoul National University’s Next-Generation Convergence Technology Institute and established a US subsidiary company called Naturegenic Inc. G+Flas Life Sciences, Inc has conducted joint research with KBP, a global leader in the production of Ebola antibodies in the United States, conducted joint research with NOMAD, a global leader in plant-based protein expression systems, and established its branch in Gplus Osong Gene Scissor New Drug Research Center in Cheombok Complex.

The company develops CRISPR, a gene scissors technology, CRISPR PLUS, Genetic scissors design technology that maximizes the accuracy and editing efficiency of CRISPR gene scissors, Cancerase, a CRISPR anticancer drug platform, PDB Platform or Plant-derived Biopharmaceuticals Platform, a biopharmaceutical production system applied with glycoengineering technology, and Non-GMO CRISPR Healthy Seeds, a Non-GMO Glyco-engineering technology.

## Funding rounds

- Series C, Aug 22, 2019, $9.9M — Smilegate Investment, AlpenRoute Asset Management, NewFlight, Chong Kun Dang Holdings Corp.
- Series B, Jul 19, 2018, $12M — Midas International Asset Management, Time Folio Asset Management, DS Asset Management
- Series A, Mar 31, 2017, $3.8M — Korea Development Bank, The Wells Investment, The Seed Investment

## Investors

- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series A
- The Wells Investment (https://capitalatlas.ai/funds/the-wells-investment) — Series A
- The Seed Investment (https://capitalatlas.ai/funds/the-seed-investment) — Series A
- Midas International Asset Management (https://capitalatlas.ai/funds/midas-international-asset-management) — Series B
- Time Folio Asset Management — Series B
- DS Asset Management (https://capitalatlas.ai/funds/ds-asset-management) — Series B
- Smilegate Investment (https://capitalatlas.ai/funds/smilegate-investment) — Series C
- AlpenRoute Asset Management — Series C
- NewFlight — Series C
- Chong Kun Dang Holdings Corp. — Series C